Milestone Pharmaceuticals (MIST) PT Lowered to $17 at Oppenheimer
Tweet
Share
E-mailGet Alerts MIST Hot Sheet
Price: $1.21 --0%
Rating Summary:
8 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 7 | New: 4
Rating Summary:
8 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 7 | New: 4
Join SI Premium – FREE
Oppenheimer analyst Leland Gershell lowered the price target on Milestone Pharmaceuticals (NASDAQ: MIST) to $17.00 (from $18.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on Milestone Pharmaceuticals (MIST)
- Ultrapar Holding (UGP) PT Raised to $7.90 at UBS
- FireFly Metals Ltd (FFM:AU) PT Raised to AUD3 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
